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0022-2836 © 2012 Elsevier Ltd. Open accThe ability of pathogenesis-related proteins of family 10 to bind a broad
spectrum of ligands is considered to play a key role for their physiological
and pathological functions. In particular, Bet v 1, an archetypical allergen
from birch pollen, is described as a highly promiscuous ligand acceptor.
However, the detailed recognition mechanisms, including speciﬁcity factors
discriminating binding properties of naturally occurring Bet v 1 variants,
are poorly understood.
Here, we report crystal structures of Bet v 1 variants in complex with an
array of ligands at a resolution of up to 1.2 Å. Residue 30 within the
hydrophobic pocket not only discriminates in high and low IgE binding Bet v
1 isoforms but also induces a drastic change in the bindingmode of themodel
ligand deoxycholate. Ternary crystal structure complexes of Bet v 1 with
several ligands together with the ﬂuorogenic reporter 1-anilino-8-naphtha-
lene sulfonate explain anomalous ﬂuorescence binding curves obtained from
1-anilino-8-naphthalene sulfonate displacement assays. The structures reveal
key interaction residues such as Tyr83 and rationalize both the binding
speciﬁcity and promiscuity of the so-called hydrophobic pocket in Bet v 1.
The intermolecular interactions of Bet v 1 reveal an unexpected complexity
that will be indispensable to fully understand its roles within the
physiological and allergenic context.© 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.ess:
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ess under CC BY-NC-ND liceIntroduction: Background and
Significance
Proteins belonging to the pathogenesis-related
protein 10 (PR-10) family are found in virtually all
studied plants.1 They are assumed to play key roles
in diverse plant defense mechanisms, because they
are commonly upregulated in response to diverse
danger signals (e.g., pathogen infection).2–5
The 17.5 kDa protein Bet v 1 is the best known
representative of the PR-10 family. It consists of
different naturally occurring isoforms, encoded by
seven genes, sharing more than 95% sequencense.
110 Bet v 1 - Ligand Complexesidentity.6 Despite being, by far, the most abundant
protein in birch pollen, the physiological function of
Bet v 1 still remains elusive. As the major pollen
allergen from theWhite birch tree (Betula pendula), Bet
v 1 represents one of the best characterized model
allergens in immunology. It is the causative agent of
diverse allergic reactions such as pollinosis and
allergic rhinitis. Worldwide, an estimated 100 million
people are sensitized to Bet v 1, especially inNorthern
America and Western Europe. In some countries,
more than 90% of all birch-pollen-sensitized patients
exhibit serum IgE reactivity towards Bet v 1.7
Based on their IgE-binding capacity, Bet v 1
isoformsweredivided intohyper- andhypoallergenic
variants.8 Despite their high sequence similarity, such
differences in IgE-binding activity are a common
characteristic within the PR-10 family: some of these
structurally, closely related proteins are potent
allergens, whereas others are in fact nonallergenic.
Crystal structures of both high and low IgE binding
Bet v 1 isoforms have been determined.9,10 However,
the molecular mechanisms rendering these proteins
allergenic remained so far elusive.
The determination of the crystal structure of a Bet
v 1a variant in 1996 and the identiﬁcation of the
hydrophobic cavity marked a milestone in under-
standing of its function.9 In 2002, the afﬁnity of Bet v
1 towards a rather broad spectrum of ligands was
described using a ﬂuorescent assay.11
Hereby, the strong ﬂuorescence increase of 1-
anilino-8-naphthalene sulfonate (ANS) upon bind-
ing to hydrophobic protein patches is exploited.
With the use of an ANS displacement assay, the
binding of several—potentially—physiologically
relevant ligands to the hydrophobic cavity of Bet v
1 could be identiﬁed. In 2003, the crystal structure of
Bet v 1l in complex with the steroid deoxycholate
(DXC) was solved.10 These results suggested that
the physiological role of Bet v 1 is most likely the
binding, transport, or storage of small lipidic plant
mediators such as steroids, cytokinins, or ﬂavo-
noids. In accordance with that, several crystal
structures of structurally closely related proteins
with ligands bound in the hydrophobic cavity were
determined, including PR-10 protein LIPR-10.2B
from Lupinus luteus in complex with trans-zeatin
and N,N′-diphenylurea,12,13 as well as the structural
homologue VrCSBP from Vigna radiata in complex
with trans-zeatin.14
Further support for the importance of its ligand
binding properties was deduced from structural
relation of Bet v 1 with the START domain of human
MLN64 protein, which is involved in steroid
binding.15
The accumulated, massive evidence for physio-
logically relevant ligand binding of Bet v 1 is
contrasted by a lack of structural and mechanistic
understanding of the binding properties: There is
nothing known about differences in ligand accep-tance to distinct Bet v 1 isoforms. Such studies
would be particularly important as the natural
isoforms also differ in amino acids forming the
surface of the hydrophobic binding pocket. Similarly,
it is unknown whether ligand binding induces
(possibly isoform-speciﬁc) conformational changes
within Bet v 1, which may again inﬂuence its
allergenic activity. Moreover, ANS displacement
assay data were controversial for some ligands,
calling for detailed structural information.
To address such questions, we determined a set of
high-resolution complex structures comprising the
high IgE binding Bet v 1 isoforms a and j. Using DXC
as a model ligand, we identiﬁed residue 30 as crucial
for ligand coordination differences in high and low
IgE binding Bet v 1 isoforms. We report ternary
binding of different ligands simultaneously to Bet v
1a, resulting in changes in both ligand conformation
and binding sites compared to the binary complexes.
These ﬁndings result in a detailed chemical mapping
of the binding pocket, illustrating the complexity of
ligand binding to Bet v 1.
Results
Quality of the structure
The presented Bet v 1 structures are solved in a
resolution range from 1.16 to 2.10 Å with similar
overall crystal characteristics (Tables 1 and 2). All
structures exhibit the classical Bet v 1 fold, consisting
of a seven-stranded antiparallel β-sheet (β1–β7),
two short α-helices (α1 and α2) connecting β1 and
β2, a long C-terminal α-helix (α3), and the glycine-
rich loop motif between β2 and β3 (Fig. 1). The
arrangement of these structural features builds up a
large hydrophobic cavity (Fig. 1a and b). Ligand
binding does not affect the overall fold of the protein.
However, minor local rearrangementswere observed
upon ligand binding, as described below.
High-resolution structures of high IgE binding
variants Bet v 1a and j
Apo Bet v 1a could now be solved at unmatched
accuracy, to a resolution of 1.51 Å. Additionally, we
could determine for the ﬁrst time the structure of
variant Bet v 1j, at near atomic resolution (1.16 Å).
The electron density maps are of outstanding
quality, allowing reliable modeling of alternative
conformations and solvent molecules. Remarkably,
within the loop connecting β7 with the C-terminal
helix α3, the backbone adopts a continuous spec-
trum of conformation, resulting in a blurred density
distribution (in particular residues G124, D125, and
H126). We observed this ﬂexibility of the loop
consistently in nearly all solved structures. This is
in line with the crystal packing, which offers space
Table 1. Overview of crystal structures and ligands
Bet v 1 isoform PDB ID Resolution (Å) Ligand Ligand structure
Bet v 1a 4A88 1.51 — —
Bet v 1j 4A8U 1.16 —
Bet v 1a 4A80 1.96 ANS
Bet v 1j 4A8V 1.23 ANS
Bet v 1a 4A81 2.05 ANS and DXC
Bet v 1a 4A83 1.54 DXC
Bet v 1a F30V 4A84 1.50 DXC
Bet v 1a 4A87 1.24 Naringenin
Bet v 1a 4A85 1.40 Kinetin
Bet v 1a 4A86 1.58 ANS and kinetin
Bet v 1a 4A8G 2.10 NDSB-256
111Bet v 1 - Ligand Complexesfor almost unrestricted movements in that region of
the protein.
Bet v 1 isoform relation
There are six amino acid differences, mostly
conservative, between the crystallized isoforms Bet
v 1a and j (j bracketed): T(A)9, N(S)82, I(V)91, D(N)
109, S(N)117, and V(I)133. Since both isoforms
reportedly strongly bind IgE,8 the exhibited muta-
tions seem to be rather neutral in this context.
Solvent molecules map the overall chemical
properties of the protein
The following description of the solvent repre-
sents apo Bet v 1j, the highest-resolution structure at1.16 Å. Besides the protein, we modeled 207 water
molecules into the asymmetric unit as well as
several molecules derived from the crystallization
buffer, including four 2-methyl-2,4-pentanediols
(MPDs), one Tris buffer molecule, and eight sulfate
ions. This allowed us to map the solvent structure
surrounding and permeating the protein to un-
precedented accuracy. The negatively charged
sulfate ions were located at the protein surface,
whereas the MPDs and several water molecules
were found within the hydrophobic cavity. Tris
was located at the glycine-rich loop, masking this
opening to the cavity. The solvent molecules built
up a complex hydrogen-bonding network,
highlighting the existence of solvent-accessible
polar anchor sites within the hydrophobic cavity
(Fig. 1d).
Table 2. X-ray data collection and model reﬁnement statistics
Bet v 1 isoform
and ligand A J A DXC
A F30V
DXC A ANS J ANS A Naringenin A Kinetin
A ANS
kinetin
A ANS
DXC A NDSB-256
Accession number 4A88 4A8U 4A83 4A84 4A80 4A8V 4A87 4A85 4A86 4A81 4A8G
Data collection
Space groupCell P21 P21 P21 P21 P21 P21 P21 P21 P21 P21 P21
X-ray source Synchro Synchro Synchro Synchro Synchro Synchro Synchro Synchro Synchro Rot. anode Rot. anode
Cell dimensions
1000
a (Å) 32.6 32.7 32.6 32.6 32.7 32.8 32.6 32.7 32.6 32.6 32.7
b (Å) 55.4 55.7 56.1 56.0 55.6 56.0 55.4 55.9 55.6 55.8 55.7
c (Å) 37.9 38.0 38.1 38.0 38.0 38.1 37.9 38.0 38.0 37.8 38.0
α/β/γ (°) 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90 90/93/90
Wavelength (Å) 0.91841 0.91841 0.91841 0.91841 0.91841 0.91841 0.91841 0.91841 0.91841 1.5418 1.5418
Number of unique
reﬂections
20,772 46,196 20,001 21,271 8488 39,178 37,419 22,328 17,743 7579 7052
Resolution (Å) 37.8–1.51 38.0–1.16 38.0–1.54 32.5–1.50 37.9–1.96 28.2–1.23 25.2–1.24 32.6–1.40 37.9–1.59 37.8–2.05 38.0–2.10
Rmerge (%) 0.050 (0.130) 0.040 (0.140) 0.040 (0.090) 0.110 (0.740) 0.040 (0.060) 0.080 (0.150) 0.060 (0.170) 0.050 (0.220) 0.050 (0.460) 0.050 (0.160) 0.060 (0.140)
Completeness (%) 97.9 (85.6) 98.1 (88.1) 98.3 (88.8) 97.3 (96.0) 90.5 (98.8) 98.3 (88.8) 97.9 (88.4) 82.8 (85.8) 96.2 (93.6) 88.3 (90.5) 87.9 (93.7)
Redundancy 3.6 (2.8) 3.6 (3.2) 3.7 (3.2) 3.1 (2.9) 3.3 (3.3) 3.6 (2.5) 3.6 (2.8) 3.0 (2.8) 3.7 (3.8) 2.6 (2.4) 3.5 (3.5)
I/σ(I) 16.7 (6.6) 17.0 (7.3) 19.3 (9.7) 4.90 (2.10) 11.1 (21.8) 11.5 (5.3) 12.7 (5.2) 11.8 (3.9) 15.9 (2.8) 13.0 (5.9) 16.6 (8.0)
Wilson B-factor 13.5 6.7 14.1 14.2 10.3 8.2 10.1 11.9 18.5 18.7 15.0
Reﬁnement statistics
Resolution
range (Å)
37.8–1.51 38.0–1.16 38.0–1.54 37.9–1.50 37.9–1.96 38.0–1.23 37.8–1.24 38.0–1.40 37.9–1.59 37.8–2.05 38.0–2.10
Number of unique
reﬂections
19,696 43,861 18,973 20,173 8487 37,186 35,510 21,237 16,818 7189 6705
Rwork/Rfree (%) 11.12/16.79 11.90/14.86 12.28/16.82 16.49/24.31 14.43/20.52 14.43/20.52 12.64/16.23 11.86/17.97 13.547/20.67 16.19/23.01 16.25/24.90
Number of atoms
Protein 1319 1338 1369 1267 1267 1364 1368 1298 1304 1245 1277
Water 215 207 140 188 115 185 191 150 145 108 12
Ligands 51 80 89 69 41 65 67 89 57 71 32
rmsd from ideal values
Bond lengths (Å) 0.012 0.010 0.009 0.014 0.007 0.015 0.014 0.020 0.012 0.016 0.015
Bond angles (°) 1.453 1.576 1.485 1.846 1.102 1.751 1.698 1.027 1.461 1.851 1.681
Average
B-factors (Å2)
13.7 11.0 13.4 14.1 13.4 12.1 14.1 14.3 18.4 20.6 16.5
Protein 14.2 11.4 14.6 15.2 14.6 12.5 14.9 14.9 19.8 22.8 14.9
Solvent 34.4 27.4 32.5 19.1 34.8 28.4 31.5 36.0 35.6 44.9 51.4
Ligands — — 17.8 32.8 27.8 30.9 34.9 33.2 37.9 32.4 27.3
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Fig. 1. Structure of Bet v 1j. (a) Topology model of Bet v 1j. α-Helices are indicated as cylinders, ﬂanking the seven-
stranded β-sheet. Throughout the article, the identical standard orientation is maintained, unless indicated otherwise. (b)
Stereo representation of the overall structure, oriented and colored according to the topology model. The hydrophobic
cavity is shown as blue mesh. Cavity entries (ɛ1–ɛ3) are indicated by arrows. (c) Solvent-accessible surface color coded by
its electrostatic potential. Red and blue colors indicate negative and positive (partial) charges, respectively. (d) Cut-open
surface presentation of the hydrophobic cavity. By removing the C-terminal helix, solvent molecules bound to the
hydrophobic pocket become visible. The cut-open interface is indicated as semitransparent surface in gray.
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sites within the cavity
The hydrophobic cavity of Bet v 1 was accessible
to solvent and small molecules at three distinct entry
sites (Fig. 1b). One opening (entry ɛ1) was located
at the ﬂexible loop connecting β7 with α3. This
entry was bordered by eight residues (F62, P63,
F64, P90, Q132, A135, S136, and M139), creating a
relatively nonpolar access route to the cavity. A
second small opening (entry ɛ2) with a diameter of
∼6 Å was surrounded by residues Y5, T7, V133,
and K137. The third entry (entry ɛ3) was located at
the opposite side of the protein. It is partly formedby the glycine-rich loop and framed by the
residues I23, L24, D25, D27, T52, K54, Y81, and
I102. The residues bordering the three entries are
equally conserved in high and low IgE binding Bet
v 1 isoforms.
Relating binding properties to high and low IgE
binding Bet v 1 variants: Phe30 versus Val30
discriminates high and low IgE binding isoforms
Despite crystal structure information of high and
low IgE binding Bet v 1 isoforms,9,10 a structural–
mechanistic basis rationalizing the respective aller-
genic properties remained elusive so far. The
(b)(a) (c)
oDXC
iDXC
iDXC
Tyr83
Asn100
Phe64
oDXC
Ser136
Lys54 MPD
As
Fig. 2. DXC binding to Bet v 1a. (a) Bet v 1a in complex with two DXCmolecules, iDXC and oDXC. iDXC is bound deep
in the hydrophobic cavity; oDXC caps the cavity opening ɛ1. (b) Close-up view of the iDXC binding site with the
experimental 2Fo−Fc electron density, contoured at 1 σ. Hydrogen bonds are shown as broken lines. Here, as well as in
other views onto the cavity, the C-terminal helix is removed for clarity. (c) Close-up view of the oDXC binding site.
Coordinating residues and solvent molecules (H2O as blue spheres) are shown. Ligands are shown with their
corresponding 2Fo−Fc electron density, contoured at 1 σ over the mean.
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into “hyperallergenic” and “hypoallergenic” iso-
forms is based on their IgE-binding activity.8 We
hypothesized that there is a correlation between
these allergenic subtypes and differentiated ligand
binding properties to the hydrophobic pocket of Bet
v 1. Thus, we searched for residues that inﬂuence the
topology of the binding pocket, and subsequently
the ligand binding, to gain a detailed understanding
of isoform-dependent binding properties of Bet v 1.
Sequence alignment of high IgE binding (Bet v 1a, e,
and j) with the low IgE binding variants (d, g, and l)
revealed ﬁve hallmark residues strictly discriminat-
ing these two classes (Supplementary Fig. 1). These
are F30V/I, S57N, S112C, I113V, and D125N for the
high and low IgE binding variants, respectively.
From these, only residue 30 is directly inﬂuencing
the topology of the hydrophobic cavity.
Identification of a suitable model compound to
identify distinguishing binding determinants in
the hydrophobic pocket
To investigate the possible implications of F30V
on ligand binding to the hydrophobic pocket in Bet
v 1, we analyzed all Bet v 1 and homologue
structures, as deposited in the Protein Data Bank
(PDB IDs 3E85,12 2QIM,13 2FLH,14 3IE5,16 1IFV,17
and 1FM410)†. DXC appeared as a candidate ligand
to discriminate amino acid exchanges at position 30
in Bet v 1, as this ligand was expected to clash with
Phe at this position. Thus, we chose DXC as a model
substance to investigate the role of residue 30 in
ligand binding to different Bet v 1 isoforms.†www.pdb.orgCrystal structure of Bet v 1a in complex
with DXC
Analogously as in the Bet v 1l–DXC complex
structure, we identiﬁed two DXC molecules bound
in tandem to Bet v 1a, occupying equivalent
positions as reported in isoform l,10 with one critical
difference as detailed below (Fig. 2a). One molecule
is bound deeply in the cavity (inner deoxycholate,
further referred to as iDXC), with almost all solvent
molecules in the cavity being displaced by it (Fig.
2b). The other DXC was found close to the loop
between β7 and α3, capping entry ɛ1 (outer
deoxycholate, oDXC, Fig. 2c). Here, the binding of
oDXC caused conformational changes of residues
K129–Q132 compared to the apo structure, repre-
senting the end of the C-terminal loop between β7
and α3. This loop thus adapts to the bound ligand,
whereas the residual Bet v 1 structure proved rather
rigid, as also conﬁrmed in other ligand complex
structures described below.
oDXC adopted a virtually identical orientation in
both Bet v 1 isoforms a and l, with comparable
polar and hydrophobic contacts facilitating the
binding. Slight differences result from isoform-
speciﬁc loop conformations that are involved in
binding.
Contrast oDXC, we found iDXC to be approxi-
mately 180° rotated in both Bet v 1 isoforms along an
axis perpendicular to the sterane C ring (Fig. 3a).
Consequently, the detailed interaction pattern chan-
ged drastically; iDXC interacts with the protein via
several hydrogen bonds (e.g., with hydroxyl group
of Tyr83) and hydrophobic contacts (e.g., with
Phe22). iDXC further exhibits a different orientation
of its alkyl side chain, which is now pointing
towards the glycine-rich loop.
(a) (b) (c)
Phe30
Val30
al30 al30
Phe30
Fig. 3. Residue 30 decides the coordination of the iDXC. (a) Comparison of iDXC in Bet v 1a (yellow) and Bet v 1l (PDB
ID 1fm4; pink), with the corresponding residues 30 being highlighted. The F30 side chain would clash with iDXC binding
in the orientation as it was observed in Bet v 1l; these contacts apparently induced a different orientation of iDXC in Bet v
1a. (b) Comparison of iDXC in Bet v 1a (yellow) and Bet v 1a F30V (blue). In F30Vmutant, iDXC showed the same binding
as in Bet v 1l, except for minor changes in its alkyl side-chain orientation. This clearly identiﬁes residue 30 as single
determinant for iDXC binding mode. (c) iDXC in Bet v 1a F30V with its corresponding electron density.
115Bet v 1 - Ligand ComplexesBet v 1a mutant F30V in complex with DXC
To proof that phenylalanine 30 is exclusively
responsible for the differences in iDXC binding to
Bet v 1a compared to Bet v 1l, we engineered a Bet v
1a F30V mutant18 and solved its crystal structure in
complex with DXC (Fig. 3b and c). Similar to the
wild-type Bet v 1a structure, we identiﬁed two DXC
molecules in the cavity, with the loop preceding the
C-terminal helix being displaced by the carboxylic
acid moiety of oDXC.
Detailed analysis of both DXC binding sites
revealed the same polar and hydrophobic interac-
tions as described for low IgE binding Bet v 1l.10
Consequently, iDXC featured exactly the same
arrangement as in Bet v 1l, that is, rotated around
the axis perpendicular to the sterane C as compared
to Bet v 1a. This unambiguously proves that residue
30 is the crucial determinant for the orientation of
iDXC within the hydrophobic core of Bet v 1.
Mechanistic interpretation of ANS displacement
assay by ligand crystal structures
Mogensen et al. established an assay for the
detection of ligand binding to Bet v 1, based on the
increasing ﬂuorescence signal of ANS at 474 nm
when binding to a hydrophobic patch or cavity of a
protein.11 Displacement of ANS out of the cavity by
another ligand comes along with a decrease in the
ﬂuorescent signal. Herewith, interaction between
Bet v 1 and a number of ligands was shown.
Bet v 1 in complex with ANS
We have selected a set of ligands that were
characterized by the ANS assay11 to structurallyinvestigate the detection mechanism; in particular,
we aimed (a) to reliably map the putative binding
sites within the cavity, (b) to explain ligand-speciﬁc
changes in the ANS ﬂuorescence signal, and thus (c)
to reconcile conﬂicting assay results. As a reference,
we solved the binary complex structures of Bet v 1a
and Bet v 1j in complex with ANS (Fig. 4a).
Details on the binding site
For both isoforms, we identiﬁed one ANS mole-
cule bound into the cavity, located beneath entry ɛ2.
ANS formed two H-bonds with the side chains of
Y83 and N118 (Fig. 4b). It further interacted with the
protein via hydrophobic contacts (e.g., F22, I102).
In the apo-form (uncomplexed) of Bet v 1a, eight
water molecules were located near the ANS binding
site, which were displaced upon ANS binding. ANS
is mostly harbored by hydrophobic residues, with
only limited access to bulk solvent via entry ɛ1 (Figs.
1b and 4a). ANS binding induced only very limited
changes in Bet v 1 structure, for example, a shift in
the side-chain conformation of K137, enlarging
entry ɛ2. ANS binding to Bet v 1j was found
basically the same as for Bet v 1a.
The identiﬁed residues coordinating the ligand are
in accordance with a model proposed by Mogensen
et al.;11 using two-dimensional NMR, they correctly
identiﬁed two of the interacting residues (Y83 and
I102). Our ﬁndings further suggest that ANS enters
the cavity via ɛ2.
Bet v 1a in complex with naringenin
Naringenin is a plant pigment hormone belonging
to the family of the ﬂavonoids, representing a ligand
class that can be of physiological relevance.
(a) (b)
(c) (d)
Glu Kinetinnin
2.1
sn118
sn118
ANS3
45°
MPD
Fig. 4. ANS binding site. (a) Bet v 1a with ANS bound to the hydrophobic core. The binding site is located beneath the
entry ɛ2, cf., Fig. 1b. (b–d) Series of close-up views on different ligands to Bet v 1 near the ANS binding site. Hydrogen-
bond coordinating residues and solvent molecules (H2O as blue spheres) are displayed. Ligands are superimposed by
their corresponding electron density (2Fo−Fc, contoured at different σ levels). (b) ANS bound to Bet v 1j, coordinated by
H-bonds between its sulfonate group and Y83 and N118. (c) Naringenin bound to Bet v 1a. In addition to hydrogen bonds
and hydrophobic interactions, naringenin is sodium bridged with Asn118. The sodium ion is shown in purple, with the
bond lengths given in angstroms. (d) Kinetin bound to Bet v 1a. Kinetin is predominantly coordinated by hydrophobic
contacts. An alternate kinetin conformation (with approximately 20% occupancy) is shown in pink.
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1 by ANS displacement assay.11 According to these
results, naringenin has to bind at the same site or in
close proximity to the binding site occupied by ANS.
Confirmation of the expected binding site
We determined the structure of the binary
complex of Bet v 1a with one naringenin molecule.
The identiﬁed binding site for naringenin over-
lapped the ANS site, consistent with the results of
the ANS displacement assay.
Overall comparison of the binding of naringenin
with that of ANS revealed that its benzopyrandouble ring system was occupying the binding site
of the ANS naphthalene. Interestingly, its hydro-
xyphenyl pointed towards the inner part of the
hydrophobic cavity, whereas the allegedly more
hydrophobic phenyl ring of ANS pointed towards
the solvent (Fig. 4b and c).
Naringenin was coordinated by several hydrogen
bonds and hydrophobic contacts. Additionally, the
benzopyran keto and hydroxyl oxygens were
sodium bridged to the Oδ of N118. The changes in
protein structure caused by naringenin binding
corresponded to those observed for ANS binding,
in particular a change in the side-chain conforma-
tion of K137.
ANS displacement assay
0:1 1:1 2:1 3:1 10:1
ligand : protein ratio
Bet v 1a : DXCBet v 1a : kinetin Bet v 1a : NDSB-256
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Fig. 5. ANS displacement assay. Changes in the
ﬂuorescence (ΔF/F0) of ANS signal induced by three
ligands (kinetin, NDSB-256, and DXC) in different molar
ratios. Bet v 1a (10 μM ﬁnal concentration) was incubated
at 4 °C overnight with the corresponding ligand.
Fluorescence emission intensities of ANS (50 μM ﬁnal
concentration) at 486 nm are shown. Kinetin titration
(pink) initially increased the ﬂuorescent signal. Very high
kinetin concentrations (10:1 ratio) led to a decrease of
ﬂuorescence, but the signal remained still higher com-
pared to Bet v 1a with ANS. NDSB-256 titration (green)
decreased the ﬂuorescence signal and remained stable for
all tested ligand:protein ratios. DXC (cyan) titration led to
a loss in ﬂuorescence signal. After an intermediate plateau,
a further decrease in ﬂuorescence could be observed at 10-
fold excess of DXC.
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Kinetin is a plant hormone of the group of
cytokinins. In ANS displacement assays, it caused
an anomalous effect, increasing the ﬂuorescent
signal of ANS upon kinetin binding (Fig. 5).11 This
indicates that kinetin is not displacing ANS
completely from the protein but induces an even
more apolar ANS binding environment. Alternative
models were proposed in order to account for the
observed anomalous ﬂuorescence effect, based on in
silico modeling studies or known binding patterns
in the related P-loop motif.11,19 Contrasting these
suggestions, crystal structures of two Bet v 1
homologous proteins in complex with zeatin, a
plant hormone highly similar to kinetin, revealed
cytokinin binding sites within the cavity (PDB IDs
2QIM13 and 2FLH14). We wanted to identify the
binding site of kinetin to Bet v 1 to explain the
increasing ANS ﬂuorescence upon kinetin binding.Identification of the binding site
We found electron density corresponding to one
kinetin molecule beneath entry ɛ2, overlapping the
binding site of ANS (Fig. 4d). Kinetin occupied two
alternative conformations related by a 180° rotation,
with the furan ring pointing into the cavity andtowards the protein surface, respectively. Kinetin
binding was predominantly mediated by hydro-
phobic interactions (e.g., F22, I102). The lack of
directed polar interactions helps to explain why the
kinetin conformation is not locked into a unique
conformation but may wobble around an average
orientation, consistent with blurred electron density.
Notably, this binary Bet v 1 kinetin complex
structure cannot explain the ANS assay results but
would rather suggest a decrease of the ﬂuorescence
signal due to ANS displacement.
Bet v 1a in ternary complex with kinetin and ANS
These apparently conﬂicting ﬁndings prompted
us to determine the ternary complex structure of Bet
v 1a with ANS and kinetin (Fig. 6a). We found ANS
to occupy a binding site identical with the binary Bet
v 1–ANS complex. Accordingly, kinetin bound to a
Bet v 1 site that differed from the binary Bet v 1–
kinetin complex (Fig. 6b and c). We found kinetin
ﬂipped about 180° around the furan ring, pointing
with its adenine system towards ɛ3 and the glycine-
rich loop. The furan ring binding site turned out to
be invariant in both the binary and ternary complex
and thus seems to determine the kinetin position
(Fig. 6d).
This structure underscores that kinetin does not
displace ANS but rather adapts to a lipophilic
binding site conferred by Bet v 1 and ANS.
Conversely, kinetin binding changes the immediate
environment of ANS; the hydrophobic kinetin is
displacing waters in the neighborhood of ANS, as
found in the binary Bet v 1–ANS structure. This
stripping of water molecules decreases the polarity
of the ANS environment and explains the observed
increase of the ANS ﬂuorescence signal in the
presence of kinetin.
The conclusion that the presence of kinetin in close
proximity to ANS, rather than changes of the protein
itself, is responsible for the increased ANS signal is
further supported by the fact that binding of
different ligands had no inﬂuence on the conforma-
tion of Bet v 1.
Our crystallographic ﬁndings demonstrate a
higher afﬁnity of ANS than kinetin towards its
primary binding site within Bet v 1, in agreement
with ligand afﬁnities as deduced from ﬂuorescence
measurments.11 When kinetin concentrations were
further increased, a reduction of the ﬂuorescence was
detected; this biphasic behavior is consistent with the
law of mass, where a partial ANS displacement by
massive excess of kinetin is to be expected.
Bet v 1a in ternary complex with DXC and ANS
ANS assay with DXC resulted in a decrease of
ﬂuorescence (Fig. 5), which could indicate a (partial)
(a) (b)
(c) (d)
ANS
Kinetin
ANS
Kinetin
15°
Fig. 6. Ternary complex of Bet v 1a with ANS and kinetin. Ligands bound in the ternary complex are shown in yellow.
For comparison, ligands from binary complexes are shown in pink (ANS) and blue (kinetin). (a) Overall view of Bet v 1a
with ANS and kinetin bound in the hydrophobic core. (b) Superposition of ANS and kinetin as bound in the respective
binary complexes (cf., Fig. 4b and c) results in overlapping binding modes. For clarity, only kinetin conformation A is
shown. (c) Close-up view of ANS and kinetin bound simultaneously to Bet v 1a. ANS is coordinated similar to the binary
complex. Thus, the presence of ANS in the cavity displaces kinetin to a secondary binding site. (d) Comparison of kinetin
coordination in the binary and ternary complex. The furan ring was located at the same site, indicating a role as anchor for
kinetin in the cavity.
118 Bet v 1 - Ligand Complexesdisplacement of ANS. However, a comparison of the
ligand binding sites from the respective binary
complex structures solved in this study revealed
that it could be sterically possible for Bet v 1 to bind
ANS and DXC simultaneously.
We solved the structure of Bet v 1a in ternary
complex with ANS and iDXC (Fig. 7a). While weconﬁrmed both ligands to occupy the binding sites
that were to be expected from the respective binary
complexes (Fig. 7b), after careful reﬁnement, we
identiﬁed an important change in the ANS orienta-
tion: The ANS was rotated for almost 180° at C11 of
the aniline ring as compared to the orientation found
in the binary complex (Figs. 7c and 4b). As a
(a) (b) (c)
ANS
ANS
20° 45°
iDXC
iDXC
Fig. 7. Ternary complex of Bet v 1a with ANS and DXC. (a) Bet v 1a with ANS and DXC bound in the hydrophobic
cavity. (b) Close-up view of ANS and kinetin simultaneously bound to Bet v 1a with the corresponding electron density.
Both ligands occupy the same binding sites as identiﬁed in the corresponding binary complexes. (c) Comparison of ANS
coordination in the binary (pink) and ternary (yellow) complex. The presence of DXC caused a change in the relative
orientation of ANS, pointing now towards the protein surface with its sulfonate group.
119Bet v 1 - Ligand Complexesconsequence, the sulfonate group occupied the
position of the naphthalene ring linked with aniline
in the secondary ANS complex and vice versa.
Careful inspection and structural analysis
revealed why in the ternary complex (Bet v 1a–
ANS–DXC) was a reorientation of the ANS relative
to the binary Bet v 1a–ANS structure induced: The
ligand conformations, as found in the binary
complexes, would bring three oxygens in close
proximity (Y83 hydroxyl, iDXC C12 hydroxyl, and
ANS sulfonate oxygen). Such an arrangement, while
sterically acceptable, would cause electrostatic re-
pulsions that caused the ANS to ﬂip over, as
observed in the ternary complex.
As revealed by the binary and ternary complex
crystal structures, ANS bound in two alternative
modes depending on the presence of DXC. This
observation provides a possible explanation for the
loss in ANS ﬂuorescence signal upon DXC binding,
albeit ANS is still bound to Bet v 1. The alternative
ANS binding modes exhibit different environments
that are likely to give rise to different ﬂuorescence
signals. Additionally, DXC may reduce the binding
afﬁnity, and consequently the occupancy, of ANS,
which may also reduce its ﬂuorescence signal.
As with kinetin, we found a biphasic change in
ﬂuorescence signal with high DXC concentrations
(Fig. 5). This further reduction may relate to DXC
binding to the oDXC binding site, which was not
occupied in the ternary complex crystal structure.
This ﬁnding suggests that binding of oDXC may
negatively cooperate with the binding of ANS via
long-range interactions. This long-range effect may
possibly be mediated by conformational changes in
the C-terminal loop that are caused upon oDXC
binding. Hence, as described for kinetin, a massive
excess of ligand could lead to partial ANSdisplacement and consequently a loss of ﬂuores-
cence signal.
Bet v 1a in complex with a sulfobetaine molecule
In an unbiased approach to further map the Bet v 1
ligand binding, we screened a commercially avail-
able compound collection with afﬁnity to hydro-
phobic proteins (“Detergent screen”, Hampton
Research) by native PAGE. From the initial hits, a
sulfobetaine derivative [non-detergent sulfobetaine
256 (NDSB-256)] could be conﬁrmed in the ANS
displacement assay (Fig. 5). We identiﬁed one
NDSB-256 molecule in the cavity, partly overlap-
ping the binding sites of ANS (with its sulfonate
group) and iDXC (with its phenyl group) (Fig. 8). As
for kinetin in its binary structure, the binding of this
ligand is not promoted by polar contacts. This
structure of Bet v 1 complexed with another
synthetic compound underscores the promiscuity
of the lipophilic binding site of Bet v 1 towards a
broad spectrum of amphiphilic ligands.
Discussion
Physicochemical mechanisms and driving
forces underlying Bet v 1 ligand binding
The presented structures allow a detailed descrip-
tion of the characteristics that make Bet v 1 a very
potent and ﬂexible ligand acceptor. The excellent
resolution (better than 1.2 Å) provides details of
both the protein and the included solvent and
ligands with unmatched accuracy. Thus, we can
describe ligand-induced changes in the hydrophobic
cavity in detail.
(a) (b) (c)
Tyr83
NDSB-
256
Tyr
Phe30 Phe21
1
Fig. 8. NDSB-256 binding to Bet v 1a. (a) Bet v 1a in complex with the sulfobetaine NDSB-256. (b) Close-up view of
NDSB-256 molecule with its corresponding electron density. The ligand is coordinated predominantly by hydrophobic
contacts. (c) Comparison of ligand binding sites in the corresponding binary complexes. NDSB-256 (yellow) overlaps the
binding sites of both ANS and iDXC (purple). Interestingly, the sulfate moieties of NDSB-256 and ANS almost overlay.
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molecules, comprising water as well as molecules
from crystallization buffers. In all complex struc-
tures presented, several solvent molecules are
displaced by ligands. In contrast to the massive
inﬂuence on the hydration shell of the protein, the
structure of the protein itself, and particularly of the
residues creating the inner surface of the cavity, is
not affected by binding of any of the presented
ligands. From a physicochemical perspective, these
ﬁndings enable us to draw to important conclu-
sions: (i) ligand binding to Bet v 1 is primarily
entropically driven, whereby clusters of solvent
molecules are stripped off the protein surface,
releasing according degrees of freedom; (ii) the so-
called hydrophobic binding pocket of Bet v 1 is
actually amphiphilic.
Biological implications
DXC has been employed previously as a model
system to study ligand binding to Bet v 1.10 We
similarly capitalized on DXC as a model to
speciﬁcally investigate the impact of residue 30 on
ligand binding towards variable Bet v 1 isoforms.
Hence, it is particularly tempting to translate our
results to physiologically and immunologically
relevant ligands that possibly discriminate high
and low IgE binding Bet v 1.
Binding of steroids
Bet v 1 is assumed to act as a steroid carrier in
plants. Markovic-Housley et al. reported brassino-
lide (BRA) binding to Bet v 1l by mass spectrom-
etry. Furthermore, they docked BRA into the
binding pocket of Bet v 1l using DXC as template.10
BRA is present in plant pollen at signiﬁcant levels20and regulates growth processes and plant
development.21 Although BRA differs from DXC
in parts of the polycyclic ring structure and the
alkyl side chain, it could be ﬁtted to both the iDXC
and oDXC binding site in Bet v 1l. Steroid binding
to PR-10 proteins was further corroborated by the
binding of castasterone, a phytosteroid highly
similar to BRA, to the hydrophobic pocket of the
major cherry allergen Pru av 1.15 Pru av 1 exhibits
Val30, similar to low IgE binding Bet v 1 variants.
The iDXC binding site in high IgE binding
isoforms such as Bet v 1a is considerably constricted
by the characteristic Phe30 as compared to low IgE
binding Bet v 1 isoforms or Pru av 1 with V30. To
test whether phytosteroids could bind to high IgE
binding isoforms in a conformation as suggested for
Bet v 1l and Pru av 1, we modeled BRA (coordinates
used from PDB ID 3RJ022) into Bet v 1a by
superimposing its ring systems with iDXC (Supple-
mentary Fig. 2). In this orientation, the alkyl side
chain of BRA points towards the glycine-rich loop
(ɛ3). Compared to DXC, BRA exhibits an extension
of the alkyl side chain by one carbon and two
additional hydroxyl groups, together making it
much more bulky than DXC. The cavity builds up
a narrow tunnel towards ɛ3, which is further
restrained in high IgE binding Bet v 1 by Phe30.
Thus, the cavity in Bet v 1a does not provide the
required space for BRA binding similarly to DXC,
leading to steric clashes between its side chain and
the protein. Consequently, we can exclude BRA or
related phytosteroids to bind to the inner binding
niche of high IgE binding Bet v 1 variants (F30) as
suggested for Bet v 1l and Pru av 1.10,15 However,
Bet v 1a is, by far, the most abundant isoform in
birch pollen.23 Thus, a physiological function
alternative to plant steroid carriage or storage for
this Bet v 1 variant should be considered.
121Bet v 1 - Ligand ComplexesInteraction of allergens with lipopolysaccharide
Lipopolysaccharide (LPS) strongly stimulates an
innate immune response, which can induce an
acquired immune response, in particular via TH1
cells.24,25 Therefore, it is interesting that a majority
of allergens are thought to be lipid binding
proteins.26 This suggests that an intrinsic adjuvant
activity by allergens relates to the bound lipidic
compounds and may thus provide a mechanism
that contributes to allergenicity.27 For Bet v 1,
binding of various fatty acids into the cavity was
shown by ANS assay.11 Further, it can interact with
phospholipidic vesicles at low pH.28 A model
proposed by Mattila and Renkonen for Bet v 1–
phospholipid interaction19 can easily be translated
to LPS. Accordingly, fatty acids could enter the
cavity via ɛ3 at the glycine-rich loop.
The loop should serve as anchor point for the polar
head group, consistent with the experimentally
observed coordination of Tris observed in our crystal
structures. Interestingly, Phe30 is located beneath
the glycine-rich loop and thus directly inﬂuences the
topology of this particular cavity opening.
Currently, there is no experimental data for Bet v
1–LPS interaction available. Albeit speculative, Phe/
Val30 could act as speciﬁc trigger for binding of LPS
or other large hydrophobic molecules, thus inﬂuenc-
ing the polarization of subsequent immune response.
Ligand binding promiscuity and ternary
complexes of Bet v 1
We can ascertain that (1) several ligands can
share the same binding site within Bet v 1; (2) Bet v
1 can coordinate the same ligand in different
orientations at one distinct binding site; (3) Bet v
1 can bind one ligand at different binding sites,
depending on the presence of another ligand; (4)
differences in the binding pocket topology of Bet v
1 isoforms are mainly caused by residue 30 and
result in remarkable alterations in ligand coordina-
tion; (5) Bet v 1 is capable of binding two different
ligands simultaneously.
For the latter, we identiﬁed two mechanisms: (a)
non-overlapping primary binding sites sterically
allow the presence of two ligands; (b) overlapping
primary sites result in the displacement of one ligand
to a secondary anchor point within the cavity.
However, other than the structurally observed
ternary complexes are realistic. For instance, DXC
and kinetin show no sterical conﬂicts in their primary
binding sites, Figs. 2 and 4. This ternary complex is in
accordance with Koistinen et al., describing distinct,
non-overlapping anchor points for these ligands in
homologues birch protein PR-10c.29 Furthermore,
concomitant binding of phytosteroids and other
plant mediators such as cytokinins and ﬂavonoids
is thinkable in low IgE binding Bet v 1 variants.Conclusion
The architecture of the Bet v 1 binding pocket is
optimized for its promiscuous ligand binding that is
probably related with storage and/or transport of a
spectrum of lipidic mediators. Importantly, the
binding promiscuity is complemented by speciﬁc
interactions that discern high and low IgE binding
Bet v 1 isoforms. The combination of isoform-
dependent and context-dependent binding modes
for a single deﬁned ligand suggests that the
physiological function of this remarkable allergen
is even more complex as thought hitherto. In the
light of its complex interactome, we propose to
study Bet v 1 as a “dressed allergen”, where isoform-
dependent ligand complexes may prime the im-
mune response to Bet v 1.Materials and Methods
Protein preparation
Recombinant Bet v 1a and Bet v 1j were expressed in
Escherichia coli strain BL21(DE3), using a modiﬁed pET-
28b vector, lacking the N-terminal 6His-tag. Cells grew in
600 ml LB medium supplemented with 20 μg/ml
kanamycin at 37 °C to an OD600 (optical density at 600 nm) of
1.0. After adding 1 mM IPTG, expression was performed
for 4 h at 37 °C. Protein was puriﬁed as described
elsewhere,30 with some minor changes of the protocol. As
a ﬁnal polishing step, size-exclusion chromatography was
performed using a Superdex75 column with a running
buffer of 20 mM imidazole, pH 7.4, and 50 mM NaCl.
Crystallization of Bet v 1
Bet v 1a crystals were obtained by sitting drop vapor
diffusion, using 5 mg/ml protein concentration. The
crystallization buffer was composed of 2.0 M ammonium
sulfate as main precipitant and 1.5% MPD. High-quality
Bet v 1j crystals were obtained using micro-seeding.31
Micro-seeds were obtained by low-quality Bet v 1j
crystals, grown in 2.5 M ammonium sulfate and 1%
MPD. Crystals were seeded into equilibrated drops of the
same crystallization conditions as used for Bet v 1a.
Crystallization of Bet v 1–ligand complexes
Bet v 1–ligand complexes were obtained using three
techniques: soaking, co-crystallization of protein with
ligand, and micro-seeding of apo-Bet crystals into equil-
ibrated co-crystallization drops.
Data collection and structure determination
Crystals were ﬂash frozen in a stream of nitrogen gas at
100 K. X-ray diffraction data sets were collected at
beamline 14.1 at Berliner Elektronenspeicherring-Gesell-
schaft für Synchrotronstrahlung (BESSY II, Berlin/
122 Bet v 1 - Ligand ComplexesAdlershof), at beamline 14-4 at the European Synchrotron
Radiation Facility (ESRF, Grenoble), and in-house using a
BrukerMicrostar rotating anode generatormountedwith a
Mar345dtb detector. Diffraction datawere indexed, scaled,
and further processed using CCP4 software suite.32 The
1.16 Å structure of apo-Bet v 1j was solved by molecular
replacement, using Phaser.33 As a search model, Bet v 1l
(PDB ID 1FM410) was used. For all subsequently solved
structures, Bet v 1j was used as a searchmodel. Reﬁnement
was performed using Refmac534 and monitored through-
out using an Rfree calculated with 5% of the unique
reﬂections. Model building was performed in Coot.35 All
ﬁgures were generated using PyMOL.36 Data collection
and processing statistics are summarized in Table 2.
ANS displacement assay
Fifty microliters of protein solution (10 μM ﬁnal
concentration) was mixed with ligands in a 96-well UV-
Star plate in different molar ratios, typically 1:1, 1:2, 1:3,
and 1:10. Mixtures were incubated overnight at 4 °C. Prior
to the measurements, 50 μl of ANS (50 μM ﬁnal
concentration) was added, and the mixtures were incu-
bated for another 5 min at room temperature. ANS was
excited at 350 nm, and measurements were performed
from 400 to 600 nm (in 2-nm steps). Blanks of ligand alone
as well as ligand with ANS were subtracted.
Structure validation
Prior to deposition, the quality of all models was checked
using MolProbity,37 NQ-Flipper,38 and PROCHECK.39
Bet v 1 nomenclature
The designation of Bet v 1 variants as originally
published was used for consistency.40 In parentheses,
the ofﬁcial http://www.iuisonline.org International
Union of Immunological Societies nomenclature is given:
Bet v 1a (Bet v 1.0101), Bet v 1d (Bet v 1.0401), Bet v 1e (Bet
v 1.0501), Bet v 1g (Bet v 1.0701), Bet v 1j (Bet v 1.0801), and
Bet v 1l (Bet v 1.1001).
Accession numbers
Coordinates have been deposited in the PDB with
accession codes 4A80, 4A81, 4A83, 4A84, 4A85, 4A86,
4A87, 4A88, 4A8G, 4A8V, and 4A8U.Acknowledgements
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